| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0029-7844(99)00565-7 |
| P698 | PubMed publication ID | 10711543 |
| P50 | author | Kari Alitalo | Q6370341 |
| P2093 | author name string | E Halmesmäki | |
| P Vuorela | |||
| H Weich | |||
| C Hornig | |||
| S Helske | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 353-357 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Obstetrics and Gynecology | Q7075543 |
| P1476 | title | Amniotic fluid--soluble vascular endothelial growth factor receptor-1 in preeclampsia | |
| P478 | volume | 95 |
| Q35010082 | An increase in vascular endothelial growth factor (VEGF) and VEGF soluble receptor-1 (sFlt-1) are associated with early recurrent spontaneous abortion |
| Q35994847 | Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia |
| Q34075013 | Angiogenesis and chronic kidney disease |
| Q34086932 | Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection |
| Q38426343 | Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis. |
| Q34155902 | Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model |
| Q45344058 | De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice |
| Q35764454 | Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies |
| Q44707133 | Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy. |
| Q35015402 | Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes |
| Q29615916 | Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia |
| Q35950212 | Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia |
| Q36189578 | Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments |
| Q35362708 | Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice |
| Q34937179 | Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy |
| Q34505704 | In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy |
| Q27007059 | Is inflammation the cause of pre-eclampsia? |
| Q39245493 | Magnesium sulfate therapy of preeclampsia: an old tool with new mechanism of action and prospect in management and prophylaxis |
| Q33826353 | Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy |
| Q34442921 | Mitochondrial Channel Opener Diazoxide Attenuates Hypoxia-Induced sFlt-1 Release in Human Choriocarcinoma Cells |
| Q54901493 | Molecular Mechanisms of Preeclampsia. |
| Q58214894 | Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria |
| Q38989371 | New scope in angiogenesis: role of vascular endothelial growth factor (VEGF), NO, lipid peroxidation, and vitamin E in the pathophysiology of pre-eclampsia among Egyptian females |
| Q37483999 | Placental ischemia and breast cancer risk after preeclampsia: tying the knot |
| Q37114991 | Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections |
| Q91815900 | Pre-eclampsia: pathogenesis, novel diagnostics and therapies |
| Q37172203 | Predictors of Impaired Postpartum Renal Function in Women after Preeclampsia: Results of a Prospective Single Center Study. |
| Q27000388 | Preeclampsia, hypoxia, thrombosis, and inflammation |
| Q37311066 | Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model |
| Q24813046 | Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells |
| Q35118673 | Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysis |
| Q33783531 | Role of biomarkers in early detection of preeclampsia |
| Q58593104 | Screening of differentially expressed proteins from syncytiotrophoblast for severe early-onset preeclampsia in women with gestational diabetes mellitus using tandem mass tag quantitative proteomics |
| Q34391174 | Sildenafil Inhibits Advanced Glycation End Products-induced sFlt-1 Release Through Upregulation of Heme Oxygenase-1. |
| Q45831979 | Soluble VEGFR-1 in pathophysiology of pregnancies complicated by hypertensive disorders: the Indian scenario |
| Q39012642 | THE AUTODIGESTION HYPOTHESIS AND RECEPTOR CLEAVAGE IN DIABETES AND HYPERTENSION. |
| Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
| Q35037064 | The biology of preeclampsia |
| Q36131296 | The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia |
| Q34920656 | The endocrinology of pre-eclampsia |
| Q61845344 | The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation |
| Q34470845 | Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid |
| Q34073285 | Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1. |
| Q44973244 | VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing |
| Q37520761 | Vascular endothelial growth factor gene polymorphisms and pregnancy |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q35009293 | Vascular endothelial growth factor receptor family genes: when did the three genes phylogenetically segregate? |
Search more.